(Q35623909)

9 August 2017

title

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies (English)

1 reference

9 August 2017

7

Muin J Khoury

1 reference

9 August 2017

2

Sheri D Schully

1 reference

9 August 2017

Patricia A Deverka

1

1 reference

9 August 2017

Naoko Ishibe

3

1 reference

9 August 2017

Josh J Carlson

4

1 reference

9 August 2017

Andrew Freedman

5

1 reference

9 August 2017

Katrina A B Goddard

6

1 reference

9 August 2017

Scott D Ramsey

8

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

9 August 2017

1 reference

9 August 2017

volume

14

1 reference

9 August 2017

issue

7

1 reference

9 August 2017

page(s)

656-662

1 reference

https://scigraph.springernature.com/pub.10.1038/gim.2012.3

9 August 2017

exact match

0 references

cites work

Use of Oncotype DX in Women with Node-Positive Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Use of epidermal growth factor receptor mutation analysis in patients with advanced non-small-cell lung cancer to determine erlotinib use as first-line therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Patient-Centered Outcomes Research Institute: the intersection of science and health care

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Comparative effectiveness research: Policy context, methods development and research infrastructure

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Genomic medicine--an updated primer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Translational research in cancer genetics: the road less traveled

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

The genomic applications in practice and prevention network

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4437504

Gene expression profiling of breast cancer to select women for adjuvant chemotherapy

25 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22481130

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FGIM.2012.3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GIM.2012.3

1 reference

9 August 2017

1 reference

9 August 2017

1 reference